Kush Arvind
Insider CIK 1986806 · IKT Director · RYZB Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IKT Inhibikase Therapeutics, I | A Award deriv | 2026-06-26 | 2026-06-30 | 155,000 | — | $0 | 155,000 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-06-30 | 2025-07-02 | 108,176 | — | $0 | 108,176 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-02-14 | 2025-02-19 | 56,600 | — | $0 | 56,600 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-02-14 | 2025-02-19 | 116,585 | — | $0 | 116,585 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2024-10-21 | 2024-10-23 | 60,000 | — | $0 | 60,000 | SEC↗ |
| IKT Inhibikase Therapeutics, I | P Buy | 2024-10-21 | 2024-10-23 | 145,000 | $1.37 | $198.7K | 145,000 | SEC↗ |
| RYZB RayzeBio, Inc. | D To issuer deriv | 2024-02-26 | 2024-02-27 | 301,745 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | D To issuer deriv | 2024-02-26 | 2024-02-27 | 164,000 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | D To issuer deriv | 2024-02-26 | 2024-02-27 | 149,777 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | D To issuer | 2024-02-26 | 2024-02-27 | 78,433 | $62.50 | $4.90M | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | A Award deriv | 2023-11-17 | 2023-11-17 | 164,000 | — | $0 | 164,000 | SEC↗ |